PLUS THERAPEUTICS Inc — Cash Flow (NASDAQ:PSTV) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 8.43 M10.3 M13 M12.9 M10.6 M 15.76 M Cash from investing activities 493 K82 K759 K160 K4.11 M 159 K Cash from financing activities 319 K20.42 M13.45 M3.44 M6.19 M 27.51 M Free cash flow 8.03 M10.3 M13 M12.9 M9.91 M 15.71 M

PLUS THERAPEUTICS Inc

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

新闻

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q4 Loss, Beats Revenue Estimates

Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering - Slideshow (NASDAQ:PSTV) 2026-01-30

H.C. Wainwright下调Plus Therapeutics股票目标价至1美元

H.C. Wainwright lowers Plus Therapeutics stock price target on equity offering

Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering Transcript

Plus Therapeutics outlines 2026 goals for cancer treatments and diagnostics

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.09%

美国股市收低；截至收盘道琼斯工业平均指数下跌0.09%

Plus Therapeutics以每单位0.38美元定价1500万美元公开发行

Plus Therapeutics prices $15 million public offering at $0.38 per unit

Crude Oil Gains Over 1%; US Retail Sales Rise 0.6% In November - BriaCell Therapeutics (NASDAQ:BCTX), Clover Health Investments (NASDAQ:CLOV)

Penny Cancer Stock Plus Therapeutics Raises $15 Million At Discount, Stock Plunges - Plus Therapeutics (NASDAQ:PSTV)